Maguire WF, Chi DC, Agrawal S, Joeng HK, et al. FDA Approval Summary: Niraparib Plus Abiraterone Acetate Fixed Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res 2025 Jul 17. doi: 10.1158/1078-0432.CCR-25-0883.
PMID: 40673886